Indeed, elevated plasma C5a levels in COVID-19 patients are consistent with the clear role of C5a in promoting lung sequestration of leukocytes and pulmonary dysfunction, that reflects the severity of the disease. The gene discussed is C5AR1; the disease is COVID-19.